Aims Several international professional bodies have produced and disseminated clinical practice guidelines (CPGs) for smoking cessation. However, to date, the quality of guidelines for use in the Irish context has never been appraised and explored. The aim of this study was to identify and evaluate the quality of methodological rigours and transparency used in guidelines for smoking cessation (for specic groups including: general adult population; persons with mental illness; and pregnant women). Methods The research for the relevant smoking cessation guidelines was conducted using a systematic search strategy of scientic databases (including guideline websites; PubMed; and Google ®) from January 2006 to June 2017. The quality of the CPGs was independently assessed by at least two assessors using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument, and specic recommendations in guidelines were evaluated. Domain scores were considered of sucient quality when ≥ 60% and of good quality when ≥ 80%. Results Nine guidelines were retrieved. Five guidelines scored ≥ 60% in at least four domains. The median score for the scope and purpose domain was 80% (Range: 61 to 94%). The median score for the stakeholder involvement domain was 63% (Range: 26 to 85%), and six guidelines scored ≥ 60%. The median score for the rigour of development domain was 39% (Range: 23 to 77%), and four guidelines scored ≥ 60%. The median score for clarity of presentation domain was 89% (Range: 56 to 96%), and eight guidelines scored ≥ 60%. The median score the applicability domain was 39% (Range: 21 to 57%). None of guidelines scored ≥ 60%. The median score for the editorial independence domain was 78% (Range: 0 to 90%); only seven guidelines scored ≥ 60%. Conclusions Smoking cessation guideline quality assessment varied across all six AGREE II domains, demonstrating the importance of using a formal appraisal tool prior to guideline adaptation and implementation into clinical settings. Our ndings have demonstrated higher scores among the most recent guidelines, reecting improvement in the quality of guideline development over time. Methodology and editorial independence were particular concerns and this assessment also highlighted a need for contextualisation to the Irish healthcare system. In conclusion, the plan for Ireland is to adapt rather than simply adopt existing guidelines.
Download full-text PDF |
Source |
---|
PLoS One
January 2025
Department of Vascular Surgery, Charm Vascular Clinic, Seoul, Republic of Korea.
Background: Abdominal aortic aneurysm (AAA) is more common in Non-small cell lung cancer (NSCLC) patients. Considering that ruptured AAA is potentially fatal, timely management of AAA would result in long-term survival benefits. We assess the prevalence and characteristics of AAA in resectable NSCLC patients who would benefit from AAA surveillance.
View Article and Find Full Text PDFClin Genitourin Cancer
November 2024
Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Background: There is a lack of published data on real-world cabozantinib use in patients with advanced renal cell carcinoma after prior vascular endothelial growth factor (VEGF)-targeted therapy.
Methods: CASSIOPE was a real-world, prospective, multicenter, non-interventional postauthorization safety study of cabozantinib in adult patients with advanced renal cell carcinoma in Europe following prior VEGF-targeted treatment (NCT03419572). Endpoints included cabozantinib utilization (dose modifications due to adverse events [AEs; primary endpoint], dose, dose modifications, and treatment duration), safety, effectiveness (progression-free survival [PFS], overall survival [OS], best overall response [BOR]), and healthcare resource utilization.
J Pers Med
December 2024
Department of Radiology, University Hospital Tuebingen, 72076 Tübingen, Germany.
: Current guidelines recommend Cisplatin/Gemcitabine/Durvalumab as first-line treatment for inoperable or recurrent cholangiocarcinoma (CCA). Molecular tumor boards (MTB) have the expertise to support organ-specific tumor boards with evidence-based treatment recommendations for subsequent lines of treatment, based on genomic tumor data and scientific evidence. This study evaluates the adoption of an MTB at a comprehensive cancer center in Germany and whether actionable genetic alterations are associated with specific imaging phenotypes.
View Article and Find Full Text PDFAnn Vasc Surg
December 2024
Department of Cardiovascular Surgery, Bursa City Hospital, Bursa, Turkey. Electronic address:
J Vasc Surg
December 2024
Department of Surgery; Baptist Health South Florida at Boca Raton Regional Hospital, Boca Raton, Florida. Electronic address:
Objective: Enhanced Recovery After Surgery (ERAS) clinical pathways have demonstrated improved perioperative outcomes after major surgery. However, its adoption within vascular surgery has been limited. In this study, we examined the impact of an ERAS protocol with multimodal anesthesia on open abdominal aortic aneurysm (AAA) repair by comparing early outcomes before and after its implementation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!